Phaseline

Companies › ORIC Pharmaceuticals

ORIC Pharmaceuticals: clinical trials, targets and expected readouts

3 active drug programs in 4 registered trials: 3 Phase 1, 1 Phase 3; Oncology; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Rinzimetostat
NAMPT inhibitor
NAMPTPhase 3Metastatic Castration Resistant Prostate CancerMar 2028
ORIC-114
Tyrosine kinase inhibitor targeting EGFR and HER2
–Phase 1Solid TumorsDec 2026
ORIC-944
ORIC-944 (mechanism not specified in registry text)
–Phase 1Metastatic Prostate CancerJun 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06816992ORIC-114Phase 1Solid TumorsOncologyDec 2026
NCT05315700ORIC-114Phase 1Solid TumorsOncologyJun 2027
NCT05413421ORIC-944Phase 1Metastatic Prostate CancerOncologyJun 2027
NCT07723248RinzimetostatPhase 3Metastatic Castration Resistant Prostate CancerOncologyMar 2028

From the company's SEC filings

Cash and short-term investments of $265m on 2026-06-30; operating cash outflow about $130m a year; runway about 24 months at that burn, to Jul 2028; 1 of 1 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Private offerings reported to the SEC (Form D)

Specialist investors

Held by 8 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.

Targets

NAMPT (1)

Companies with the same targets

Metro International Biotech Remedy Plan

Companies built like this

ArriVent BioPharma Cogent Biosciences Olema Pharmaceuticals Immunome Day One Biopharmaceuticals

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.